539 related articles for article (PubMed ID: 27263494)
1. Microglial activation during epileptogenesis in a mouse model of tuberous sclerosis complex.
Zhang B; Zou J; Han L; Rensing N; Wong M
Epilepsia; 2016 Aug; 57(8):1317-25. PubMed ID: 27263494
[TBL] [Abstract][Full Text] [Related]
2. The specificity and role of microglia in epileptogenesis in mouse models of tuberous sclerosis complex.
Zhang B; Zou J; Han L; Beeler B; Friedman JL; Griffin E; Piao YS; Rensing NR; Wong M
Epilepsia; 2018 Sep; 59(9):1796-1806. PubMed ID: 30079598
[TBL] [Abstract][Full Text] [Related]
3. The natural history and treatment of epilepsy in a murine model of tuberous sclerosis.
Erbayat-Altay E; Zeng LH; Xu L; Gutmann DH; Wong M
Epilepsia; 2007 Aug; 48(8):1470-6. PubMed ID: 17484760
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex.
Zeng LH; Xu L; Gutmann DH; Wong M
Ann Neurol; 2008 Apr; 63(4):444-53. PubMed ID: 18389497
[TBL] [Abstract][Full Text] [Related]
5. Postnatal reduction of tuberous sclerosis complex 1 expression in astrocytes and neurons causes seizures in an age-dependent manner.
Zou J; Zhang B; Gutmann DH; Wong M
Epilepsia; 2017 Dec; 58(12):2053-2063. PubMed ID: 29023667
[TBL] [Abstract][Full Text] [Related]
6. Modulation of astrocyte glutamate transporters decreases seizures in a mouse model of Tuberous Sclerosis Complex.
Zeng LH; Bero AW; Zhang B; Holtzman DM; Wong M
Neurobiol Dis; 2010 Mar; 37(3):764-71. PubMed ID: 20045054
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory mechanisms contribute to the neurological manifestations of tuberous sclerosis complex.
Zhang B; Zou J; Rensing NR; Yang M; Wong M
Neurobiol Dis; 2015 Aug; 80():70-9. PubMed ID: 26003087
[TBL] [Abstract][Full Text] [Related]
8. Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex.
Zeng LH; Rensing NR; Zhang B; Gutmann DH; Gambello MJ; Wong M
Hum Mol Genet; 2011 Feb; 20(3):445-54. PubMed ID: 21062901
[TBL] [Abstract][Full Text] [Related]
9. Epileptogenesis and reduced inward rectifier potassium current in tuberous sclerosis complex-1-deficient astrocytes.
Jansen LA; Uhlmann EJ; Crino PB; Gutmann DH; Wong M
Epilepsia; 2005 Dec; 46(12):1871-80. PubMed ID: 16393152
[TBL] [Abstract][Full Text] [Related]
10. Cerebral vascular and blood brain-barrier abnormalities in a mouse model of epilepsy and tuberous sclerosis complex.
Guo D; Zhang B; Han L; Rensing NR; Wong M
Epilepsia; 2024 Feb; 65(2):483-496. PubMed ID: 38049961
[TBL] [Abstract][Full Text] [Related]
11. Early developmental electroencephalography abnormalities, neonatal seizures, and induced spasms in a mouse model of tuberous sclerosis complex.
Rensing N; Johnson KJ; Foutz TJ; Friedman JL; Galindo R; Wong M
Epilepsia; 2020 May; 61(5):879-891. PubMed ID: 32274803
[TBL] [Abstract][Full Text] [Related]
12. Expression profiling in tuberous sclerosis complex (TSC) knockout mouse astrocytes to characterize human TSC brain pathology.
Ess KC; Uhlmann EJ; Li W; Li H; Declue JE; Crino PB; Gutmann DH
Glia; 2004 Apr; 46(1):28-40. PubMed ID: 14999811
[TBL] [Abstract][Full Text] [Related]
13. Tuberous sclerosis and epilepsy: role of astrocytes.
Wong M; Crino PB
Glia; 2012 Aug; 60(8):1244-50. PubMed ID: 22438024
[TBL] [Abstract][Full Text] [Related]
14. Abnormal glutamate homeostasis and impaired synaptic plasticity and learning in a mouse model of tuberous sclerosis complex.
Zeng LH; Ouyang Y; Gazit V; Cirrito JR; Jansen LA; Ess KC; Yamada KA; Wozniak DF; Holtzman DM; Gutmann DH; Wong M
Neurobiol Dis; 2007 Nov; 28(2):184-96. PubMed ID: 17714952
[TBL] [Abstract][Full Text] [Related]
15. Complex alterations in microglial M1/M2 markers during the development of epilepsy in two mouse models.
Benson MJ; Manzanero S; Borges K
Epilepsia; 2015 Jun; 56(6):895-905. PubMed ID: 25847097
[TBL] [Abstract][Full Text] [Related]
16. Impaired glial glutamate transport in a mouse tuberous sclerosis epilepsy model.
Wong M; Ess KC; Uhlmann EJ; Jansen LA; Li W; Crino PB; Mennerick S; Yamada KA; Gutmann DH
Ann Neurol; 2003 Aug; 54(2):251-6. PubMed ID: 12891680
[TBL] [Abstract][Full Text] [Related]
17. A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits.
Feliciano DM; Lin TV; Hartman NW; Bartley CM; Kubera C; Hsieh L; Lafourcade C; O'Keefe RA; Bordey A
Int J Dev Neurosci; 2013 Nov; 31(7):667-78. PubMed ID: 23485365
[TBL] [Abstract][Full Text] [Related]
18. Reduced cuprizone-induced cerebellar demyelination in mice with astrocyte-targeted production of IL-6 is associated with chronically activated, but less responsive microglia.
Petković F; Campbell IL; Gonzalez B; Castellano B
J Neuroimmunol; 2017 Sep; 310():97-102. PubMed ID: 28778453
[TBL] [Abstract][Full Text] [Related]
19. Sequential activation of microglia and astrocyte cytokine expression precedes increased Iba-1 or GFAP immunoreactivity following systemic immune challenge.
Norden DM; Trojanowski PJ; Villanueva E; Navarro E; Godbout JP
Glia; 2016 Feb; 64(2):300-16. PubMed ID: 26470014
[TBL] [Abstract][Full Text] [Related]
20. Alterations in microglial phenotype and hippocampal neuronal function in transgenic mice with astrocyte-targeted production of interleukin-10.
Almolda B; de Labra C; Barrera I; Gruart A; Delgado-Garcia JM; Villacampa N; Vilella A; Hofer MJ; Hidalgo J; Campbell IL; González B; Castellano B
Brain Behav Immun; 2015 Mar; 45():80-97. PubMed ID: 25449577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
